PPLPHARMANSEPiramal Pharma LimitedMediumNeutral
Announced Wed, 29 Apr · 16:33 IST

Audio Recording of Conference Call on the Audited Financial Results (Standalone and Consolidated) for the quarter and year ended 31st March, 2026

Investor Communications View source PDF

PPLPHARMA · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
-0.0%1-day move
₹160.56
prior close
₹161.47
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
-1.6-1.5-2.3-1.3-0.0-0.4+2.7+14.3+11.8+10.9+9.0+6.2+4.6
Up moveDown movePending
AI summary

Piramal Pharma has disclosed that the audio recording of its earnings conference call held on April 29, 2026 is available on the company website. The call covered audited financial results for the quarter and year ended March 31, 2026. This is a routine regulatory filing (Regulation 30 of SEBI LODR) informing stock exchanges and investors where to access the recording. The actual content of the earnings call — including revenue figures, profitability details, or management commentary — is not included in this filing. Investors seeking detailed financial performance or guidance would need to listen to the full recording on the company website.

Likely market impact

This filing is informational and does not contain new financial data or guidance. The stock is unlikely to react to this disclosure alone; any price movement would have occurred when the actual Q4/FY2026 results were announced separately.